ACHONDROGENESIS TYPE 2 IN A NEWBORN WITH
A NOVEL MUTATION ON THE COL2A1 GENE Dogan P1,*, Varal IG1, Gorukmez O2, Akkurt MO3, Akdag A1 *Corresponding Author: Pelin Dogan, M.D., University of Health Sciences, Bursa Yuksek Ihtisas
Teaching Hospital, Department of Pediatrics, Division of Neonatology, Yıldırım, Bursa, Turkey.
Tel.: +90-505-316-4268. Fax: +90-224-294-4000. E-mail: pelin_akbas@yahoo.com page: 89
|
CASE REPORT
A 25-year-old pregnant Syrian woman was referred
to the perinatology clinic for further screening due to a
suspected skeletal anomaly at 27 weeks’ gestation. The
previous obstetric history was uneventful and the couple
was non consanguineous. The first trimester screening was negative, while a detailed sonography scan revealed short
long bones (<1st percentile for all long bones, including
femur, tibia, fibula, humerus, radius and ulna) with a small
thorax and polihydroamnios. The family was provided genetic
counseling related to the high suspicion of lethal skeletal
dysplasia. After detailed counseling, a cordocentesis
was performed. All sonographic findings suggested skeletal
dysplasia; a conventional chromosomal analysis confirmed
a normal 46,XY karyotype, while an exome sequencing
analysis revealed ACG2. After a 10-week follow-up period,
a cesarean delivery was carried out at 39 weeks’ gestation
due to a previous history of cesarean section.
The patient had a 1 and 5 min. APGAR score of 4
and 5 at birth, respectively. The patient was intubated after
delivery due to a lack of spontaneous respiration and was
admitted to the Level III Neonatal Intensive Care Unit
(NICU), Bursa, Turkey. The birth weight was 2780 gr
(3-10 percentile), height was 38 cm (below 3 percentile),
and head circumference was 37 cm (90-97 percentile). A
physical examination revealed extremely short extremities,
abdominal distention, a small chest, a prominent forehead
and a flat nasal bridge (Figure 1). Ophthalmological examination
of the patient was normal. The patient had severe
respiratory distress, and follow-up was continued with high
frequency oscillation ventilation (HFOV), as conventional
mechanical ventilator settings failed to achieve the target
saturation level. A peripheral vascular line could not be
established due to extensive edema in the body, for which
an umbilical catheter was inserted and total parenteral
nutrition was initiated.
A cranial and abdominal ultrasound revealed normal
findings, while an X-ray examination revealed a short tubular
bone structure, metaphyseal widening, short ribs, a
small chest and a lack of ossification in the pelvis (Figure
2). A blood sample was obtained for genetic analysis with
an antenatal pre diagnosis of ACG2. An echocardiography
performed on postnatal day 4 revealed pulmonary hypertension
and the patient was administered nitric oxide therapy for 2 days. Respiratory distress persisted in the
follow-up period and the patient was followed with HFOV
due to carbon dioxide retention with conventional ventilator
settings. The patient died of respiratory insufficiency
on postnatal day 25.
Genetic Analysis. In the present study, clinical exome
sequencing and Sanger sequencing were performed, and
genomic DNA was extracted from peripheral venous blood
using a QIAamp® DNA Mini Kit (Qiagen, Ankara, Turkey).
The Clinical Exome Solution (Sophia Genetics SA,
Saint-Sulpice, Switzerland) was used for exome enrichment,
with all procedures carried out according to the
manufacturer’s protocols. This capture-based target enrichment
kit covers 4900 genes with known inherited diseases
causing mutations.
Paired-end sequencing was performed on a NextSeq
500 system (Illumina, San Diego, CA, USA) with a read
length of 150 × 2, while the base calling and image analysis
were conducted using Real-Time Analysis (integrated to
the NextSeq 500 system; Illumina) software. The BCL
(base calls) binary is converted into FASTQ utilizing the
Illumina package bcl2fastq.
All bioinformatic analyses were performed on a
Sophia DDM™ platform (Sophia Genetics SA), which
includes algorithms for alignment, calling single nucleotide
polymorphisms (SNPs) and small insertions/deletions
(Pepper™, Sophia Genetics SA patented algorithm) calling
copy number variations (Muskat™, Sophia Genetics SA
patented algorithm) and functional annotations (Moka™,
Sophia Genetics SA patented algorithm). The raw reads
were aligned to the human reference genome (GRCh37/
hg19). Variant filtering and interpretations were performed
on the Sophia DDM™ platform (Sophia Genetics SA),
and an Integrative Genomics Viewer (IGV) was used to
visualize the BAM (binary alignment map) files [5]. In
families with consanguineous marriages, homozygosity
mapping is carried out with HomSI (www.igbam.bilgem.
tubitak. gov.tr/softwares/ HomSI) [6]. Next generation
sequencing (NGS) showed a heterozygous missense variation,
c.2546G>A, p.Gly849Asp on the COL2A1 gene that
was confirmed by Sanger sequencing (Figure 3).
Genetic Results. This variant (c.2546G>A,
p.Gly849Asp) on the COL2A1 gene has not been previously
reported in the Human Gene Mutation Database
(HGMD; http://www.hgmd.cf.ac.uk/ac/index.php) or in
population studies (ExAC: Exome Aggregation Consortium
and 1000 Genomes Project), while silico analysis
programs (VarSome; DANN Score: 0.9969 and ACMG;
Likely Pathogenic) have shown that this variation may be
the cause of the disease.
|
|
|
|
|
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|
|